Home Stock

Stock Research: PolyNovo

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

PolyNovo

ASX:PNV AU000000PNV0
25
  • Value
    16
  • Growth
    63
  • Safety
    Safety
    48
  • Combined
    37
  • Sentiment
    30
  • 360° View
    360° View
    25
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PolyNovo Limited is an Australia-based medical device company focused on advanced wound care, designing, developing, and manufacturing dermal regeneration solutions. Its main businesses include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX, used for managing various wounds. In the last fiscal year, the company had a market cap of $538 million, profits of $66 million, revenue of $70 million, and 254 employees.

more
Strongest Rank Dividend Yield
Weakest Rank Capital Growth
Country Australia
Industry Health Care Supplies
Size Small
Website polynovo.com
Index
ASX 300
PolyNovo stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
16 7 6 3
Growth
63 56 97 45
Safety
Safety
48 15 12 4
Sentiment
30 57 51 41
360° View
360° View
25 15 23 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
59 49 55 55
Opinions Change
31 50 72 50
Pro Holdings
n/a 51 40 50
Market Pulse
50 64 53 38
Sentiment
30 57 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
16 7 6 3
Growth
63 56 97 45
Safety Safety
48 15 12 4
Combined
37 4 21 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
51 11 9 5
Price vs. Earnings (P/E)
28 10 5 3
Price vs. Book (P/B)
12 3 3 1
Dividend Yield
1 1 1 1
Value
16 7 6 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
80 91 96 100
Profit Growth
43 80 94 75
Capital Growth
94 1 98 1
Stock Returns
3 51 23 17
Growth
63 56 97 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
55 40 41 24
Refinancing
31 9 17 5
Liquidity
52 18 12 6
Safety Safety
48 15 12 4

Similar Stocks

Discover high‑ranked alternatives to PolyNovo and broaden your portfolio horizons.

Kelsian

ASX:KLS
Country: Australia
Industry: Highways & Railtracks
Size: Medium
Full Stock Analysis

Fukuda Denshi

TYO:6960
Country: Japan
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Regis Resources

ASX:RRL
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

Astellas Pharma

TYO:4503
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews